HIV-1 subtype J recombinant viruses in Spain
Holguín, A.; Alvarez, A.; Soriano, V.
Aids Research and Human Retroviruses 18(7): 523-529
2002
ISSN/ISBN: 0889-2229 PMID: 12015907 DOI: 10.1089/088922202317406682Document Number: 259673
Genetic characterization of HIV-1 was carried out in two women who originated in Cameroon and Equatorial Guinea, respectively, and who were diagnosed more recently as HIV-1 seropositive in Madrid, Spain. Phylogenetic studies showed that the protease-encoding gene from both individuals clustered with subtype J sequences with a high bootstrap. However, env sequences clustered with subtypes A and C, respectively. This work represents the first characterization of HIV-1 containing subtype J-like genomic regions in Spain.
Document emailed within 0-6 h
Related Documents
Wilkinson, E.; Engelbrecht, S. 2009: Molecular characterization of non-subtype C and recombinant HIV-1 viruses from Cape Town, South Africa Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 9(5): 840-846Wu, Z.; Wu, X.; Hou, Y. 2002: Generation of a series of recombinant herpes simplex viruses which can provide replicating and packaging functions for recombinant adeno-associated virus Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 16(1): 74-78
Vaĭtkiene, V.V.; Rumel', N.B.; Simanovskaia, V.K.; Taros, L.I.; Golubev, D.B. 1973: Immunologic characteristics of the neuraminidase of influenza a viruses serologic subtype 2 Voprosy Virusologii 18(5): 560-564
Gitel'man, A.K.; Mukazhanova, G.N.; Kharitonenkov, I.G. 1981: Radioimmunological study of the hemagglutinin of influenza viruses subtype H1N1 Voprosy Virusologii 6: 712-716
Leneva, I.A.; Shuster, A.M. 2006: Antiviral etiotropic chemicals: efficacy against influenza A viruses A subtype H5N1 Voprosy Virusologii 51(5): 4-7
Saiatov, M.K.; Asanova, S.E.; Beĭsembaeva, R.U.; Karal'nik, B.V. 1985: Erythrocyte antibody diagnostic agents for determining the type and subtype of influenza viruses Voprosy Virusologii 30(1): 39-43
Sayan, M.; Kaptan, F.; Ormen, B.; Türker, N. 2014: Molecular characterization of complex recombinant HIV-1 CRF06_cpx subtype detected in Turkey Mikrobiyoloji Bulteni 48(1): 160-167
Wan, C.-H.; Fu, G.-H.; Cheng, L.-F.; Shi, S.-H.; Chen, H.-M.; Peng, C.-X.; Lin, F.; Lin, J.-S.; Huang, Y. 2012: Sequence comparison of the hemagglutinin gene of the duck-origin H9N2 subtype avian influenza viruses Bing du Xue Bao 28(2): 158-164
De Silva, T.I.; Turner, R.; Hué, S.ép.; Trikha, R.; van Tienen, C.; Onyango, C.; Jaye, A.; Foley, B.; Whittle, H.; Rowland-Jones, S.L.; Cotten, M. 2010: HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form Retrovirology 7: 82
Mehendale, S.; Sahay, S.; Thakar, M.; Sahasrabuddhe, S.; Kakade, M.; Shete, A.; Shrotri, A.; Spentzou, A.; Tarragona, T.; Stevens, G.; Kochhar, S.; Excler, J.L.; Fast, P.; Paranjape, R. 2010: Safety and immunogenicity of tgAAC09, a recombinant adeno-associated virus type 2 HIV-1 subtype C vaccine in India Indian Journal of Medical Research 132: 168-175
Burgard, E.C.; Tietz, E.I.; Neelands, T.R.; Macdonald, R.L. 1996: Properties of recombinant gamma-aminobutyric acid a receptor isoforms containing the alpha 5 subunit subtype Molecular Pharmacology 50(1): 119-127
Koulinska, I.N.; Msamanga, G.; Mwakagile, D.; Essex, M.; Renjifo, B. 2002: Common genetic arrangements among human immunodeficiency virus type 1 subtype a and D recombinant genomes vertically transmitted in Tanzania Aids Research and Human Retroviruses 18(13): 947-956
Silva, R.F.; Finkelstein, A. 1990: Recombinant viruses as poultry vaccines Journal of Reproduction and Fertility. Supplement 41: 153-162
Ramanathan, V.D.; Kumar, M.; Mahalingam, J.; Sathyamoorthy, P.; Narayanan, P.R.; Solomon, S.; Panicali, D.; Chakrabarty, S.; Cox, J.; Sayeed, E.; Ackland, J.; Verlinde, C.; Vooijs, D.; Loughran, K.; Barin, B.; Lombardo, A.; Gilmour, J.; Stevens, G.; Smith, M.S.; Tarragona-Fiol, T.; Hayes, P.; Kochhar, S.; Excler, J.-L.; Fast, P. 2009: A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers Aids Research and Human Retroviruses 25(11): 1107-1116
Timiryasova, T.M.; Chen, B.; Fodor, N.; Fodor, I. 2001: Construction of recombinant vaccinia viruses using PUV-inactivated virus as a helper Biotechniques 31(3): 534 536 538-40
Renjifo, B.; Gilbert, P.; Chaplin, B.; Vannberg, F.; Mwakagile, D.; Msamanga, G.; Hunter, D.; Fawzi, W.; Essex, M. 1999: Emerging recombinant human immunodeficiency viruses: uneven representation of the envelope V3 region Aids 13(13): 1613-1621
Boyle, D.B.; Anderson, M-Ann.; Amos, R.; Voysey, R.; Coupar, B.E.H. 2004: Construction of recombinant fowlpox viruses carrying multiple vaccine antigens and immunomodulatory molecules Biotechniques 37(1): 104-6 108-11
Senkevich, T.G.; Araslanov, R.R.; Vovk, T.S.; Loparev, V.N.; Chernos, V.I. 1989: Vaccinia and ectromelia recombinant viruses, causing an infection, characteristic for ectromelia, in mice Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 8: 20-23
Yoshikawa, M.; Kitatani, F. 1994: Clinical features and morbidity of group B diffuse interstitial pneumonia, atypical subtype, compared with group A, typical idiopathic subtype Nihon Kyobu Shikkan Gakkai Zasshi 32(7): 625-631
Bruguera, M.; Buti, M.; Diago, M.; García Bengoechea, M.; Jara, P.; Pedreira, J.A.; Ruiz Extremera, A. 1997: Indications and prescription of hepatitis A vaccine in Spain. Report of the Spain Association for the Study of the Liver Gastroenterologia y Hepatologia 20(9): 467-473